Recent studies have highlighted the pharmacological potential of pyridazines in cholinesterase inhibition, positioning them as promising candidates for treating Alzheimer’s disease (AD) and other neurodegenerative disorders. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.